Evidence map›Paper›PMID 25778396›Full record

ArticleThe Journal of biological chemistry2015

Integrins Influence the Size and Dynamics of Signaling Microclusters in a Pyk2-dependent Manner.

Maria Steblyanko, Nadia Anikeeva, Kerry S Campbell, James H Keen, Yuri Sykulev

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Spatial localization of CD16a at the human NK cell ADCC lytic synapse.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Frontiers in immunology · 2020
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Maria SteblyankoFrom the Departments of Microbiology and Immunology and.
Nadia AnikeevaFrom the Departments of Microbiology and Immunology and.
Kerry S Campbellthe Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
James H KeenBiochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 and.
Yuri SykulevFrom the Departments of Microbiology and Immunology and Yuri.Sykulev@Jefferson.edu.
Bipar · FRFox Chase Cancer Center · USThomas Jefferson University · US

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
Negative Signalling by Killer Ig-like ReceptorsR01CA083859 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CAMPBELL, KERRY S · 2000 to 2014
$3.8M
Regulation of Clathrin and Adaptor FunctionR01GM049217 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI KEEN, JAMES H · 1994 to 2016
$3.8M
Immune receptors on Cytotoxic Lymphocytes&Target CellR01AI052812 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SYKULEV, YURI · 2002 to 2012
$3.5M
Immune Receptors on Cytotoxic Lymphocytes and Target CellsR56AI052812 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SYKULEV, YURI · 2007 to 2007
$412k
Proximity between immune receptors on the cell surface and the sensitivity of TceR21CA131973 · NCI · THOMAS JEFFERSON UNIVERSITY · PI SYKULEV, YURI · 2009 to 2010
$333k
NCI NIH HHS CA083859NCI NIH HHS CA131973NCI NIH HHS P30 CA056036NCI NIH HHS R01 CA083859NCI NIH HHS R21 CA131973NIAID NIH HHS AI52812NIAID NIH HHS R01 AI052812NIAID NIH HHS R56 AI052812NIGMS NIH HHS GM49217NIGMS NIH HHS R01 GM049217
6 · The paper itself

Abstract

Integrin engagement on lymphocytes initiates "outside-in" signaling that is required for cytoskeleton remodeling and the formation of the synaptic interface. However, the mechanism by which the "outside-in" signal contributes to receptor-mediated intracellular signaling that regulates the kinetics of granule delivery and efficiency of cytolytic activity is not well understood. We have found that variations in ICAM-1 expression on tumor cells influence killing kinetics of these cells by CD16.NK-92 cytolytic effectors suggesting that changes in integrin ligation on the effector cells regulate the kinetics of cytolytic activity by the effector cells. To understand how variations of the integrin receptor ligation may alter cytolytic activity of CD16.NK-92 cells, we analyzed molecular events at the contact area of these cells exposed to planar lipid bilayers that display integrin ligands at different densities and activating CD16-specific antibodies. Changes in the extent of integrin ligation on CD16.NK-92 cells at the cell/bilayer interface revealed that the integrin signal influences the size and the dynamics of activating receptor microclusters in a Pyk2-dependent manner. Integrin-mediated changes of the intracellular signaling significantly affected the kinetics of degranulation of CD16.NK-92 cells providing evidence that integrins regulate the rate of target cell destruction in antibody-dependent cell cytotoxicity (ADCC).

Indexed as

Antibody-Dependent Cell CytotoxicityCD18 AntigensCell Line, TumorFocal Adhesion Kinase 2HumansInflammationIntegrinsIntercellular Adhesion Molecule-1Killer Cells, NaturalLigandsLipid BilayersLymphocytesProtein BindingProtein Structure, TertiaryReceptors, IgGSignal TransductionCD18 AntigensFocal Adhesion Kinase 2ICAM1 protein, humanIntegrinsIntercellular Adhesion Molecule-1LigandsLipid BilayersReceptors, IgGsrc-Family KinasesADCCcellular immune responseCytotoxic lymphocytesimmunologyIntegrin receptorskilling kineticslymphocytenatural killer cells (NK cells)signalingsignaling microclusters

Identifiers

PMID25778396
PMCPMC4424324
OpenAlexW2046686522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.